3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
Meet Veristat at the EMSO 2017 Congress, the most influential annual meeting for oncology professionals in Europe. This year's theme "Integrating science into oncology for a better patient outcome" echos the call across the industry to develop more targeted therapies to extend and improve the lives off cancer patients.
Our teams’ have the expertise and experiences to help you design, build, and run your oncology/hematology clinical development program. And, we’ll help you navigate the regulatory submission process.
Fill out the form on the right hand side of this page to schedule a time to meet with Veristat at ESMO. Even if you are not attending ESMO and want to speak with one of Veristat's experts, fill out the form.
Learn how Veristat helped a current client achieve their patient enrollment timeline for an early phase oncology clinical trial.
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...
3 min read
Apr 24, 2026 Veristat Blog
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...